OraSure Technologies to Reveal Third Quarter Insights
OraSure Technologies, Inc. (NASDAQ: OSUR) has set the stage for an enlightening earnings conference call to discuss their financial performance in the third quarter of 2024. Scheduled for 5 p.m. ET on November 6, this event aims to highlight not only the company’s financial results but also notable developments within their business operations.
Participation in the Earnings Call
Interested parties are invited to join the conference call for an in-depth look at OraSure’s recent achievements and future outlook. Those wishing to participate will need to pre-register to ensure they receive access details via email. The process is user-friendly and encourages engagement from stakeholders keen to interact with the management team.
How to Access the Webcast
For those unable to join the live call, a webcast will be made available on OraSure’s investor relations webpage. It's important for participants to click on the provided link and complete the registration at least ten minutes prior to the scheduled call time. Once the event concludes, the archived version will be accessible for approximately 90 days, allowing for flexible viewing options.
About OraSure Technologies
OraSure Technologies, often seen as a pioneer in healthcare innovations, is dedicated to transforming health through actionable insights. The company is significantly involved in improving the accessibility and quality of healthcare services globally. With its wholly-owned subsidiary, DNA Genotek Inc., OraSure is at the forefront of developing rapid diagnostic tests and sample collection devices that are essential in detecting critical medical conditions.
Global Reach and Services
OraSure's diverse portfolio caters to a wide range of clients including clinical laboratories, hospitals, physician offices, and public health organizations. The company continuously strives to enhance the effectiveness of healthcare tools available worldwide, ensuring that testing and treatment options are accessible to all.
Key Contacts Within OraSure
The company emphasizes its commitment to communication with investors and the media. Jason Plagman manages investor relations, ensuring that stakeholders receive up-to-date information. Amy Koch oversees corporate communications, working to provide timely updates and responses to media queries. Whether through direct email or public relations efforts, OraSure aims to maintain transparency and accessibility for all interested parties.
Looking Ahead
As OraSure Technologies prepares for its next earnings call, anticipation builds around the insights that will be shared. Investors and healthcare professionals alike are eager to understand the impact of the company's innovations on the market. The earnings call remains a crucial opportunity for all stakeholders to gauge how the company continues to advance its mission and meet healthcare demands effectively.
Frequently Asked Questions
What is the date and time of OraSure's earnings call?
The earnings call is scheduled for November 6 at 5 p.m. ET.
How can I participate in the earnings call?
Participants must pre-register to gain access. Details will be provided via email after registration.
Where can I find the webcast of the call?
The webcast will be available on OraSure’s investor relations page following the call.
Who are the key contacts for OraSure Technologies?
Jason Plagman leads investor relations, while Amy Koch directs corporate communications.
What types of services does OraSure offer?
OraSure specializes in rapid diagnostic tests and sample collection devices, enhancing healthcare access and quality internationally.
